The importance of medical devices

‍

In the healthcare system, medical devices form a vital and core component. Devices are primarily utilized for crucial steps like prevention, diagnosis, treatment, and rehabilitation of illnesses. Benefits of medical devices continue to expand with ongoing technological advancements and increased availability of data. Medical devices cover a wide range of diagnostic, therapeutic, and monitoring technologies. 

Diagnostic technologies such as X-ray, CT, and MRI, enable diagnosing diseases and tracking of the efficacy of a treatment/intervention. Therapeutic technologies such as pacemakers, insulin pumps enable the treatment of patients and management of chronic illnesses precisely and with low invasiveness.

Monitoring equipment, including heart rate monitors, ventilators, and glucose monitors, enables real-time monitoring of the status of a patient, ensuring timely treatment. Medical devices enhance the precision, effectiveness, and safety of medical practice. They enhance patient care and quality of life. Their significance in medicine is immense, as they continue to innovate and redefine the future of medicine.

‍

Data challenges in medtech

Medical devices are an important facilitator of the healthcare sector through the improvement of diagnostics, treatment, monitoring, and overall provision of high-quality care. Ranging from early detection of disease to enabling complicated procedures and long-term management of health. Still, the process of developing and approving the devices is mostly hampered by data issues. Among the major challenges to the process, the first is the lack of availability of large-scale, longitudinal, and diverse data sets. Longitudinal datasets help track outcomes of safety and effectiveness of devices across diverse populations. Without such information, there will be difficulty in creating products that are robust, free of bias, and generalizable between different patient populations. This makes innovation slower and also poses the risk of developing devices that may not work well across heterogeneous real-world clinical environments.

Another obstacle is the disintegration of healthcare information, which frequently resides in disconnected silos because of inadequate interoperability. For example, if data from electronic health records (EHRs) is not coupled with genomic and imaging information, it is challenging to realize how well the device performs. It becomes more challenging to achieve meaningful insights. When data is not easily comparable or integrable, it is challenging to produce insights that could guide improved device development and testing.

Further, for development and approval of devices strict regulatory requirements are present that mandate use of complete, and standardized datasets. Meeting these requirements is essential not just for regulatory approval, but also to ensure the safety and effectiveness of devices in real-world use. 

‍

The role of Real-World Data and Real-World Imaging Data 

Overcoming these challenges with enhanced data access, standardization, and collaboration among the healthcare ecosystem is essential in the provision of effective medical technologies.

Real-world evidence (RWE) is filling the data evidence gap in medical device development and evaluation. Sources of RWE include electronic health records, claims, patient registries, and some advanced data sources like imaging data and genomic data. RWE provides useful information on device use in the real world, patient outcomes, and safety in various populations. This data facilitates faster and more informed decisions for regulatory use, label changes, and postmarket surveillance once a product is on the market. By demonstrating how devices perform beyond controlled trials, RWE helps expand device indications, design optimization, and assure continued safety and effectiveness in normal medical practice.

Within RWD, real-world imaging data (RWiD) provides visual and anatomical insights that other data types cannot. RWiD will help us understand the complexity of disease presentation, anatomical variability, and device interaction with the human body. This is important for both diagnostic and interventional devices. When integrated with other clinical data, imaging will enhance decision-making across the entire device lifecycle.

‍

Use cases of Real world imaging data in medical devices 

‍

1. Gathering RWE for regulatory submissions

Imaging data plays a key role in helping medical devices get approved. Imaging endpoints are specific assessments from medical images that act as indicators of how well a medical device works or how a patient responds to the device. These endpoints provide visual proof that can be measured, standardized, and repeated, making them very useful in the approval process. For example, anatomical endpoints help focus on physical changes visible through imaging, like size, volume, device positioning, and tissue response. These endpoints help assess device placement, performance, and biocompatibility.

On the other hand, functional endpoints evaluate how devices impact physiological processes, including blood flow, tissue perfusion, and metabolic activity.

For the medical device industry, well-designed imaging endpoints offer important benefits for getting devices approved. They provide clear, measurable data on how the device performs and can show treatment effects that may not be obvious through other clinical methods. When validated properly, imaging endpoints often act as substitute endpoints. Substitute endpoints can help speed up clinical trials while meeting the FDA’s need for proof of safety and effectiveness.

‍

2. Device design optimization (labeling modifications)‍

^‍

Real-world imaging data demonstrates the performance of devices for varying body types, imaging modalities, and clinical practices.

For instance, an implantable cardiovascular prosthesis was originally approved for patients of a particular valve size on the basis of data from controlled trials. Subsequently, through the analysis of imaging data, including echocardiograms and CT scans from larger patient groups, the device operated safely and efficiently in patients with somewhat smaller valve sizes. Such data-based evidence permits the labeling to be changed by the manufacturers. This thereby allows more patients to benefit from the device.

‍

3. Post-market monitoring for safety and effectiveness and label expansion

‍

Real-world imaging data helps easily monitor how devices work in different environments and among various groups of people. This ongoing data allows identification of new side effects, observing performance trends, and understanding how devices are used by groups that might not be well represented in clinical data. Moreover, insights from RWiD can help broaden the use of devices by showing their effectiveness in new diseases or for different patient groups. This evidence increases trust in the devices and supports market growth while ensuring compliance with regulations.

For surveillance of implantable cardiac devices like pacemakers post approval, imaging data is highly beneficial. CT imaging data can demonstrate whether pacemakers have migrated away from the initial location or intervening tissue is exhibiting signs of reactions such as thrombosis or fibrosis.

By examining imaging information, manufacturers and regulators can detect device-related complications sooner, evaluate long-term safety, and modify device labeling or usage guidelines.

‍

The Segmed advantage

‍

With unparalleled visual insights that help ensure the safety of patients, treatment effectiveness, and the performance of medical products, real-world imaging data (RWiD) has now become an integral part of the medical device industry. RWiD provides high-resolution, objective evidence, allowing for earlier detection, comprehensive therapy assessment, and improved long-term monitoring of medical interventions. 

At Segmed, we provide access to 100M+ high-quality, regulatory-grade real-world imaging datasets from across 10 continents. Connect with us to explore how our diverse, high-quality tokenized imaging datasets can enhance post-market surveillance, support regulatory compliance, and provide critical insights to optimize the safety and performance of your medical devices.